In lab experiments using tissue samples cultured
from cystic fibrosis patients, scientists at the UNC School of Medicine and the UNC Marsico Lung Institute have shown that a new CF drug counteracts the intended beneficial molecular effect of another CF drug.
Not exact matches
«We are now exploring ways to reformulate antibiotics together with relevant vitamins for delivery into
cystic fibrosis patients and assess their efficacy, so that
patients can benefit
from these findings.»
The scientists performed the tests in a laboratory setting using 100 different bacterial strains isolated
from the lungs of pediatric
cystic fibrosis patients of Seattle Children's Hospital and 42 bacterial strains isolated
from hospitalized adult
patients at UPMC.
In the Netherlands, based on research reported in 2016 in Science Translational Medicine, Clevers and colleagues are already using personalized gut organoids, derived
from rectal biopsies, to test whether
cystic fibrosis patients will benefit
from available drugs.
«Because airway spheres
from a
patient with
cystic fibrosis do not swell in our assay but airway spheres
from a healthy person do, we can see whether adding a certain drug or combination of drugs causes them to swell more.
A multi-drug resistant infection that can cause life - threatening illness in people with
cystic fibrosis (CF) and can spread
from patient to
patient has spread globally and is becoming increasingly virulent, according to new research published today in the journal Science.
Senior co-author Dr Alastair Innes
from Western General Hospital, Edinburgh, UK adds, «Publication of this trial is a landmark for
cystic fibrosis patients and we are particularly grateful to the many
patients across the UK who gave their time and effort to participate and make this collaborative venture a success.»
On topics ranging
from the proper care of terminal cancer
patients to how the best
cystic fibrosis doctors push their
patients» life spans far beyond the mean, they have certainly educated this colleague.
He benefits
from a medication that targets the underlying cause of the disease for a small subset of
cystic fibrosis patients.»
Ten Years of Improvement Innovation in
Cystic Fibrosis Care includes reports on a range of improvement initiatives, ranging
from the impact of
patient education on improving adherence to critical daily treatments, and strategies for boosting nutritional status.
New research comparing
cystic fibrosis patients in the United States and Canada showed that, although the
patients» nutritional status and lung function improved in both countries over the period
from 1990 to 2013, the rate of improvement was faster in the United States.
And the technique will benefit not just cancer research but research into every disease driven by gene mutations,
from cystic fibrosis to Alzheimer's disease — ultimately enabling customized treatments for
patients in a way never before possible.
The study was funded by the U.S.
Cystic Fibrosis Foundation using data
from 45,456
patients in the U.S.
Cystic Fibrosis Foundation Registry and 5,941
patients in the Canadian
Cystic Fibrosis Registry
from 1990 to 2013.
Twelve
patients from the Northern Ireland Adult and Paediatric
Cystic Fibrosis Centres participated in the study.
The study, funded by the U.S.
Cystic Fibrosis Foundation, used data
from 37,772
patients in the U.S.
Cystic Fibrosis Foundation Registry and 5,149
patients in the Canadian
Cystic Fibrosis Registry.
For example, organoids grown
from the guts of individual
cystic fibrosis patients are used to predict their response to drugs.
Pseudomonas aeruginosa can cause serious inflammations of the skin and the lung in
patients with a weakened immune system, particularly in those suffering
from the genetic disorder
cystic fibrosis.
The course will use cultures
from the Living Biobank at The HUB, which include organoids
from patients with
cystic fibrosis and various forms of cancer.
Meanwhile, Hans Clevers and colleagues applied CRISPR to disease correction in adult stem cells isolated
from two
patients with
cystic fibrosis.
As proof - of - concept, the CFTR locus was repaired in single gut stem cells
from two
Cystic Fibrosis patients, using CRISPR / Cas9 technology in conjunction with homologous recombination.
Though every CF
patient carries mutations in both copies of the same gene — coding for a protein called
cystic fibrosis transmembrane conductance regulator or CFTR — symptoms can vary widely
from patient to
patient.
This has been used for many years to break up mucus in the lungs in
patients suffering
from cystic fibrosis, asthma and bronchitis, and is often used by HIV
patients to boost their immune system.
The planTrue ™ carrier screening
from True Health employs industry - leading next - generation sequencing technology to detect whether a
patient is a carrier for conditions such as
cystic fibrosis, spinal muscular atrophy, fragile X, and many others.
Less than 2 % of diseases, such as
cystic fibrosis, Huntington's chorea, and beta thalassemia, result
from a single faulty gene, and only about 5 % of cancer
patients can attribute their diseases to heredity.